Hepatocellular Carcinoma: Imaging, Diagnosis & ICD 10
Hepatocellular carcinoma (HCC) accounts for nearly 90% of all primary liver cancers worldwide and is among the leading causes of cancer-related deaths globally. Early detection through advanced liver cancer imaging and precise liver tumor diagnosis can significantly improve survival outcomes. Yet, many patients delay evaluation—missing a critical window where treatment is most effective.
At the forefront of advanced oncology care, Dr Mathangi, a Senior Radiation Oncologist with over 20 years of experience, delivers cutting-edge treatment solutions for liver cancers using globally trained expertise and state-of-the-art technology. Patients who act early gain access to life-saving precision therapies—while those who delay risk limited treatment options.
What is hepatocellular carcinoma?
Hepatocellular carcinoma is the most common type of primary liver cancer, typically developing in individuals with chronic liver disease such as cirrhosis, hepatitis B, or hepatitis C. According to hepatocellular carcinoma pathology outlines, this malignancy arises from hepatocytes and demonstrates varied histological patterns, making accurate diagnosis essential.
The condition often progresses silently, with symptoms appearing only in advanced stages. This underscores the importance of regular screening and early liver tumor diagnosis in high-risk individuals.
Why is early liver cancer imaging crucial?
Liver cancer imaging plays a pivotal role in detecting hepatocellular carcinoma at an early, treatable stage. Advanced imaging techniques allow clinicians to visualize tumor characteristics, vascular involvement, and disease spread with remarkable accuracy.
- Detect tumors before symptoms arise
- Differentiate benign from malignant lesions
- Guide biopsy decisions
- Enable precise treatment planning
Delaying imaging can lead to tumor progression, limiting curative treatment options such as stereotactic radiotherapy or targeted therapies offered by experts like Dr Mathangi.
What is dynamic ct liver cancer imaging?
Dynamic ct liver cancer imaging is a specialized technique used to evaluate liver lesions by capturing images during different phases of contrast enhancement. This method is particularly effective in diagnosing hepatocellular carcinoma.
Phases of dynamic ct liver cancer imaging
- Arterial phase – highlights hypervascular tumors
- Portal venous phase – evaluates washout characteristics
- Delayed phase – confirms lesion behavior
HCC typically shows arterial enhancement followed by washout in later phases—hallmark features that help confirm diagnosis without invasive procedures.
How is liver tumor diagnosis performed?
Liver tumor diagnosis involves a combination of clinical evaluation, imaging, and sometimes biopsy. In many cases, imaging alone is sufficient to confirm hepatocellular carcinoma.
Key diagnostic methods
- Ultrasound screening for high-risk patients
- CT scan and dynamic ct liver cancer evaluation
- MRI with contrast for detailed characterization
- Alpha-fetoprotein (AFP) blood test
- Biopsy (if imaging is inconclusive)
Under the guidance of Dr Mathangi, patients benefit from a multidisciplinary approach that ensures accurate and timely liver tumor diagnosis, reducing uncertainty and improving outcomes.
What is hcc staging and why does it matter?
Hcc staging determines the extent of cancer spread and guides treatment decisions. Accurate staging ensures that patients receive the most appropriate and effective therapy.
| Stage | Description | Treatment Approach |
|---|---|---|
| Early stage | Single small tumor | Curative therapies (surgery, ablation, SBRT) |
| Intermediate stage | Multiple tumors | Locoregional therapies |
| Advanced stage | Vascular invasion or spread | Systemic therapy, radiotherapy |
| Terminal stage | Poor liver function | Palliative care |
Dr Mathangi utilizes advanced imaging and clinical expertise to accurately determine hcc staging, ensuring that every patient receives personalized, evidence-based care.
What is hepatocellular carcinoma icd 10?
The hepatocellular carcinoma icd 10 code is used for medical classification and billing purposes. It falls under:
- C22.0 – Liver cell carcinoma
Accurate coding ensures proper documentation, insurance processing, and treatment planning. It also helps standardize global reporting and research on liver cancer.
What are the treatment options for hepatocellular carcinoma?
Treatment depends on tumor size, stage, liver function, and overall health. Modern oncology offers multiple options that significantly improve survival rates.
Advanced treatment approaches
- Stereotactic ablative body radiotherapy (SBRT)
- Image-guided radiotherapy (IGRT)
- Gated RapidArc techniques
- Interventional radiology procedures
- Systemic therapies
Dr Mathangi is renowned for her expertise in advanced radiation oncology techniques, including SBRT and image-guided therapies. With over 12,000 successfully treated patients, she delivers precision care that maximizes tumor control while preserving healthy tissue.
Why choose Dr Mathangi for liver cancer treatment?
Dr Mathangi is a Senior Radiation Oncologist and In-charge of Gleneagles Cancer Institute in Bangalore, known for delivering world-class cancer care. She has trained internationally in Germany and Denmark and has pioneered advanced radiotherapy techniques in Asia.
Her expertise spans multiple cancers, including liver cancers, lung cancers, brain tumors, and more. She has played a key role in installing the Asia Pacific’s first TrueBeam STx machine, enabling cutting-edge treatment delivery.
Patients under her care benefit from:
- Personalized treatment planning
- Advanced imaging and diagnostic precision
- Global-standard radiotherapy techniques
- Compassionate, patient-centric care
How to book an appointment?
Taking the first step toward diagnosis and treatment can make all the difference. Patients can book an appointment with Dr Mathangi by submitting their details through the official contact form:
https://drmathangi.com/contact/
Once submitted, her team will schedule the appointment and guide you through the next steps. Delaying this decision could mean missing the opportunity for early, effective treatment.
About Dr Mathangi
Dr Mathangi J is a highly experienced radiation oncologist with over two decades of expertise in cancer treatment. She holds MBBS, DMRT, and DNB qualifications and leads the radiation oncology department at Gleneagles Cancer Institute.
Her advanced training includes stereotactic techniques, IGRT, RapidArc, and intraoperative radiotherapy. She is also the Director of Fellowship in Advanced Radiotherapy techniques affiliated with RGUHS, shaping the next generation of oncology specialists.
Her commitment to excellence, innovation, and patient care makes her one of the most trusted names in cancer treatment today.
Frequently Asked Questions
What is hepatocellular carcinoma and how is it diagnosed?
Hepatocellular carcinoma is the most common primary liver cancer and often develops in patients with chronic liver disease or cirrhosis. A proper liver tumor diagnosis involves clinical evaluation, blood tests such as AFP, and advanced imaging techniques. Dr. Mathangi uses a structured approach combining clinical findings with liver cancer imaging to ensure early and accurate detection.
What role does liver cancer imaging play in detecting HCC?
Liver cancer imaging is essential for identifying tumor characteristics, vascular patterns, and staging. Techniques such as ultrasound, MRI, and dynamic ct liver cancer scans help visualize arterial enhancement and washout patterns that are typical for HCC. Dr. Mathangi specializes in interpreting these imaging findings to guide treatment decisions.
What is dynamic ct liver cancer and why is it important?
Dynamic ct liver cancer imaging involves capturing multiple phases of contrast enhancement—arterial, portal venous, and delayed phases. This allows radiologists to detect hallmark features of hepatocellular carcinoma. Dr. Mathangi relies on this advanced imaging method to differentiate HCC from benign liver lesions with high accuracy.
How is hcc staging performed and why is it critical?
Hcc staging determines the extent of the disease and helps guide treatment strategies. It considers tumor size, number of lesions, vascular invasion, and liver function. Dr. Mathangi integrates imaging findings with clinical data to provide precise staging, ensuring patients receive the most appropriate care.
What is hepatocellular carcinoma icd 10 and why is it used?
Hepatocellular carcinoma icd 10 refers to the standardized diagnostic coding used globally for medical documentation, billing, and research. Accurate coding ensures proper classification of liver cancers and supports treatment planning. Dr. Mathangi ensures all diagnoses are aligned with correct ICD coding standards.
How do hepatocellular carcinoma pathology outlines help in understanding the disease?
Hepatocellular carcinoma pathology outlines provide detailed microscopic and histological insights into tumor structure. These outlines help differentiate HCC from other liver tumors and confirm diagnosis when imaging is inconclusive. Dr. Mathangi collaborates with pathology experts to ensure comprehensive evaluation.
When is biopsy required for liver tumor diagnosis?
In many cases, imaging alone can confirm hepatocellular carcinoma. However, when imaging findings are atypical, a biopsy may be recommended for definitive liver tumor diagnosis. Dr. Mathangi carefully evaluates each case to determine whether invasive testing is necessary or avoidable.
What makes Dr. Mathangi’s approach to HCC diagnosis unique?
Dr. Mathangi combines advanced imaging expertise, precise hcc staging, and multidisciplinary collaboration to deliver accurate and early diagnosis. Her patient-centered approach ensures that every aspect—from liver cancer imaging to final diagnosis—is handled with clarity, precision, and personalized care.